Taken together, complement C5 promotes DKD not only by activating the STAT3 pathway and inflammation in GECs but also by disrupting the gut‐kidney axis in individuals with T2DM (Figure 7). This evidence concerns the gene STAT3 and type 2 diabetes mellitus.